Klaus Godl
Chief Tech/Sci/R&D Officer at Evotec (München) GmbH
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bernhard Wimmer | M | - |
Evotec (München) GmbH
 Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Part of Evotec SE, Evotec (München) GmbH is a German company that provides manufacturing and research support services for pharmaceutical and biotechnology companies. The company is based in Neuried, Germany. The CEOs are Dirk Ullmann, Loëtitia Edith Rouxel. The company was founded in 2005 by Axel Ullrich, Hellmut Kirchner, Henrik Daub. Evotec (München was acquired by Evotec SE on April 19, 2011 for $20.40 million. | - |
| Friedrich Erath | M | - |
Evotec (München) GmbH
Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Part of Evotec SE, Evotec (München) GmbH is a German company that provides manufacturing and research support services for pharmaceutical and biotechnology companies. The company is based in Neuried, Germany. The CEOs are Dirk Ullmann, Loëtitia Edith Rouxel. The company was founded in 2005 by Axel Ullrich, Hellmut Kirchner, Henrik Daub. Evotec (München was acquired by Evotec SE on April 19, 2011 for $20.40 million. | - |
| Jürgen Schumacher | M | - |
Evotec (München) GmbH
Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Part of Evotec SE, Evotec (München) GmbH is a German company that provides manufacturing and research support services for pharmaceutical and biotechnology companies. The company is based in Neuried, Germany. The CEOs are Dirk Ullmann, Loëtitia Edith Rouxel. The company was founded in 2005 by Axel Ullrich, Hellmut Kirchner, Henrik Daub. Evotec (München was acquired by Evotec SE on April 19, 2011 for $20.40 million. | - |
| Jutta Fritz | M | - |
Evotec (München) GmbH
Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Part of Evotec SE, Evotec (München) GmbH is a German company that provides manufacturing and research support services for pharmaceutical and biotechnology companies. The company is based in Neuried, Germany. The CEOs are Dirk Ullmann, Loëtitia Edith Rouxel. The company was founded in 2005 by Axel Ullrich, Hellmut Kirchner, Henrik Daub. Evotec (München was acquired by Evotec SE on April 19, 2011 for $20.40 million. | 15 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Manfred Kroneder | M | 57 |
University of Regensburg
| 5 years |
| Axel Ullrich | M | - |
Axxima Pharmaceuticals AG
 Axxima Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services Axxima Pharmaceuticals AG provided drug discovery and development services. It was a drug discovery company in the field of kinase inhibition. It specialized in kinase-based drug discovery aimed at treating certain forms of cancer. It had also focussed on on HIV, Hepatitis C, tuberculosis and one particular herpes virus infections. The company was headquartered in Munich, Germany. | - |
| Lorenz Pfau | M | 63 |
University of Regensburg
| 8 years |
| Andreas J. Goss | M | 60 |
University of Regensburg
| 5 years |
| Edeltraud Leibrock | M | 59 |
University of Regensburg
| 8 years |
| Gerhard Mueller | M | - |
Axxima Pharmaceuticals AG
Axxima Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services Axxima Pharmaceuticals AG provided drug discovery and development services. It was a drug discovery company in the field of kinase inhibition. It specialized in kinase-based drug discovery aimed at treating certain forms of cancer. It had also focussed on on HIV, Hepatitis C, tuberculosis and one particular herpes virus infections. The company was headquartered in Munich, Germany. | - |
| Carla Eysel | F | 52 |
University of Regensburg
| 5 years |
| Bettina Orlopp | M | 54 |
University of Regensburg
| 4 years |
| Manfred G. Ismair | M | - |
University of Regensburg
| 4 years |
| Susanne Kunschert | F | 54 |
University of Regensburg
| 7 years |
| Gerhard Hausruckinger | M | 63 |
University of Regensburg
| 3 years |
| Gerhard Ertl | M | - |
University of Regensburg
| 4 years |
| Jochen Ruetz | M | 56 |
University of Regensburg
| 5 years |
| Thomas Jackermeier | M | 55 |
University of Regensburg
| 6 years |
| Arthur Koschany | M | - |
University of Regensburg
| 3 years |
| Stefan Miller | M | - |
University of Regensburg
| 3 years |
| Lesley A. Stolz | M | 60 |
GPC Biotech AG
 GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | 4 years |
| Christoph Jennen | M | 57 |
University of Regensburg
| 4 years |
| Clive Krückemeyer | M | - |
Axxima Pharmaceuticals AG
Axxima Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services Axxima Pharmaceuticals AG provided drug discovery and development services. It was a drug discovery company in the field of kinase inhibition. It specialized in kinase-based drug discovery aimed at treating certain forms of cancer. It had also focussed on on HIV, Hepatitis C, tuberculosis and one particular herpes virus infections. The company was headquartered in Munich, Germany. | - |
| Eckart Koerner | M | - |
University of Regensburg
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 24 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Klaus Godl
- Personal Network
